Infectious bronchitis virus with mutation of glycosylation site of M protein and preparation method and application thereof
A technique for bronchitis and site mutation, applied in biochemical equipment and methods, chemical equipment and methods, botany equipment and methods, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1IBV
[0053] Construction of embodiment 1 IBV M protein mutant strain N3D / N6D full-length infectious clone
[0054] Construct 5 plasmids containing 5 fragments (A to E) spanning the entire IBV genome, such as figure 1 , and BsmBI or BsaI restriction sites were introduced into the 5' and 3' ends of the fragment. In fragment A, the T7 promoter sequence is inserted upstream of the 5' end of the IBV genome, and T7 polymerase is used to promote in vitro transcription. The specific steps are as follows:
[0055] (1) Infect African green monkey kidney cells (Vero cells, ATCC) with chicken IBV. For the source and infection method of IBV, see the literature "S. Shen, et al. Emergence of a coronavirus infectious bronchitis virus mutant with a truncated 3b gene: functional characterization of the 3b protein inpathogenesis and replication.”.
[0056] (2) The total RNA extracted from IBV-infected African green monkey kidney cells (Vero cells, ATCC) by TrizoL was amplified by RT-PCR technique, ...
Embodiment 2
[0067] Embodiment 2Western blot verifies the expression of mutant virus strain protein
[0068] The Vero cells infected with the mutant IBV prepared in Example 1 were lysed with 1× RIPA buffer solution (Beiyuntian) to obtain the total protein, which was mixed with a 5-fold concentration of loading dye containing 0.1M DTT Afterwards, the cell lysate was boiled at 95°C for 5 minutes and processed by SDS-PAGE. protein in PBST buffer containing 5% skimmed milk powder (80mM Na 2 HPO 4 , 20mM NaH 2 PO 4 , 100mM NaCl, 0.1% Tween 20, pH7.5), incubated overnight at 4°C; the membrane was incubated with IBV-M or IBV-N antibody (M protein or N protein was expressed in BL21 competent (Tiangen) prokaryotic Purified and injected into rabbits, M antibody and N antibody have been disclosed in the literature "Sumoylation of the nucleocapsid protein of severe acute respiratory syndrome coronavirus") incubated for 1 hour, washed with PBST 3 times, and horseradish peroxidase (Beijing Quanquan ...
Embodiment 3
[0070] Embodiment 3 measures virus proliferation curve
[0071] Divide Vero cells by 1 × 10 5 cells / mL were inoculated on a 6-well plate (1mL cell suspension was inoculated in each well), and Vero cells were infected with wild-type IBV and mutant IBV at an MOI of 1, and harvested at different times after infection, and the virus was obtained after freezing and thawing three times The stock solution was then serially diluted 10 times to infect Vero cells on a 96-well plate. On the 3rd day after infection, the number of infected wells was read according to cytopathy (cell fusion), and the half cell infection amount (TCID) of each sample was determined by the Reed and Muench method. 50 ).
[0072] The result is as Figure 4 As shown, the virus proliferation curve shows that there is no significant difference in the proliferation of the M protein mutant and wild-type IBV strains on the cells.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com